Publications by authors named "M Rahmannia"

Introduction: Depression and anxiety are pervasive mental health disorders with substantial global burdens. Probiotics, live microorganisms known for their health benefits, have emerged as a potential therapeutic intervention for these conditions. This systematic review and meta-analysis aim to evaluate the strain-specific effects of probiotics on relieving depressive and anxiety symptoms while elucidating underlying mechanisms.

View Article and Find Full Text PDF

Diabetic patients frequently experience a serious complication known as impaired wound healing, which increases the likelihood of foot infection and limb amputation. Investigators have been looking for novel methods to treat diabetic foot ulcers (DFUs) recently. A 75-year-old woman with type one diabetes mellitus (DM) has been accepted.

View Article and Find Full Text PDF

Introduction: This manuscript offers an in-depth comparative examination of the effectiveness of higher-dose (double standard-dose and high-dose) influenza vaccines in contrast to a single standard-dose vaccine when it comes to alleviating major cardiovascular events.

Study Design: Meta-Analysis.

Methods: To conduct this study, an exhaustive search was carried out in the medical English literature using databases such as PubMed/MEDLINE, EMBASE, and the Cochrane CENTRAL until 10 April 2024.

View Article and Find Full Text PDF
Article Synopsis
  • Osteoporosis is a major health issue for people with chronic kidney disease (CKD), increasing fracture risks and complicating treatments, especially in advanced CKD stages 4 and 5.
  • A review of 12 randomized controlled trials with over 31,000 participants found that certain anti-osteoporotic medications (like teriparatide and denosumab) significantly reduce vertebral fracture risk, although their effectiveness is less pronounced in stages 4 and 5 of CKD.
  • The study shows romosozumab resulted in better improvements in bone mineral density (BMD) across all CKD stages, with no serious side effects reported for any of the treatments.
View Article and Find Full Text PDF

INTRODUCTIONTo determine the frequency of TB among patients with interstitial lung diseases (ILDs).METHODSWe performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.RESULTSTwelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.

View Article and Find Full Text PDF